Francesco Fiorentino

36PUBLICATIONS
119CO-AUTHORS
Gene and molecular therapyCheminformatics and quantitative structure-activity relationshipsHaematological tumoursRegenerative medicine (incl. stem cells)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jul 20, 2026
METTL1/WDR4 Complex: A Novel Epitranscriptomic Target at the Crossroads of RNA Methylation and Drug Discovery.

|May 05, 2026
Development of High-Affinity CHD1 Chromodomain Inhibitors.

|Apr 30, 2026
Development of Biphenyl-Substituted Uracil-Based Hydroxamic Acids (UBHAs) as Potent HDAC Inhibitors with Pro-Apoptotic Activity in Leukemia and Prostate Cancer Cells.

|Mar 27, 2026
A synergistic interaction between PRMT5 and LSD1 inhibitors in AML.

Nesteene Joy Param, Elisa Arceci, Francesco Fiorentino

|Mar 25, 2026
The ATC12 small molecule inhibits the Aurora-A/TPX2 interaction and impairs the proliferation of breast cancer cells.

Dalila Boi, Giulia Fianco, Federica Polverino

|Dec 31, 2025
Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710.

Simona Sennato, Giorgia Paldino, Cecilia Bombelli

Pageof 6

Frequent Collaborators

26 joint publications

Antonello Mai

26 joint publications

Dante Rotili

6 joint publications

Carol V Robinson

5 joint publications

Jani Reddy Bolla